nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Albert Coons: harnessing the power of the antibody
|
Arthur, Greer |
|
2016 |
4 |
3 |
p. 181-182 2 p. |
artikel |
2 |
Another STEP forward in emphysema treatment
|
Slebos, Dirk-Jan |
|
2016 |
4 |
3 |
p. 166-167 2 p. |
artikel |
3 |
Australian law could silence critics of refugee health
|
Kenyon, Georgina |
|
2016 |
4 |
3 |
p. 178- 1 p. |
artikel |
4 |
Cardiovascular and neuropsychiatric risks of varenicline
|
Fidler, Lee |
|
2016 |
4 |
3 |
p. e9-e10 nvt p. |
artikel |
5 |
Cardiovascular and neuropsychiatric risks of varenicline – Authors' reply
|
Kotz, Daniel |
|
2016 |
4 |
3 |
p. e10- 1 p. |
artikel |
6 |
Chronic Chlamydia pneumoniae lung infection: a neglected explanation for macrolide effects in wheezing and asthma?
|
Hahn, David L |
|
2016 |
4 |
3 |
p. e8- 1 p. |
artikel |
7 |
Chronic Chlamydia pneumoniae lung infection: a neglected explanation for macrolide effects in wheezing and asthma? – Authors' reply
|
Stokholm, Jakob |
|
2016 |
4 |
3 |
p. e8-e9 nvt p. |
artikel |
8 |
Defining a diagnostic gene signature for tuberculosis
|
Warner, Digby F |
|
2016 |
4 |
3 |
p. 170-171 2 p. |
artikel |
9 |
Dynamic light application therapy to reduce the incidence and duration of delirium in intensive-care patients: a randomised controlled trial
|
Simons, Koen S |
|
2016 |
4 |
3 |
p. 194-202 9 p. |
artikel |
10 |
Genome-wide expression for diagnosis of pulmonary tuberculosis: a multicohort analysis
|
Sweeney, Timothy E |
|
2016 |
4 |
3 |
p. 213-224 12 p. |
artikel |
11 |
Heavily polluted cities attempt to curb traffic emissions
|
Kirby, Tony |
|
2016 |
4 |
3 |
p. 183-184 2 p. |
artikel |
12 |
Hypoxic pulmonary hypertension in chronic lung diseases: novel vasoconstrictor pathways
|
Rowan, Simon C |
|
2016 |
4 |
3 |
p. 225-236 12 p. |
artikel |
13 |
Less is more: a shift in the surgical approach to non-small-cell lung cancer
|
Cao, Christopher |
|
2016 |
4 |
3 |
p. e11-e12 nvt p. |
artikel |
14 |
Light therapy and chronobiology in critical illness
|
Annane, Djillali |
|
2016 |
4 |
3 |
p. 167-168 2 p. |
artikel |
15 |
NICE guidance on nintedanib for treating idiopathic pulmonary fibrosis
|
Laurenson, Sophie |
|
2016 |
4 |
3 |
p. 176-177 2 p. |
artikel |
16 |
Paediatric orphan lung diseases in Asia
|
Aryan, Zahra |
|
2016 |
4 |
3 |
p. 174-175 2 p. |
artikel |
17 |
Prolonging life at all costs: quantity versus quality
|
The Lancet Respiratory Medicine, |
|
2016 |
4 |
3 |
p. 165- 1 p. |
artikel |
18 |
Pulmonary rehabilitation: the next steps
|
Steiner, Michael C |
|
2016 |
4 |
3 |
p. 172-173 2 p. |
artikel |
19 |
Resisting the use of antibiotics for viral infections
|
Tanday, Sanjay |
|
2016 |
4 |
3 |
p. 179- 1 p. |
artikel |
20 |
Rosuvastatin versus placebo for delirium in intensive care and subsequent cognitive impairment in patients with sepsis-associated acute respiratory distress syndrome: an ancillary study to a randomised controlled trial
|
Needham, Dale M |
|
2016 |
4 |
3 |
p. 203-212 10 p. |
artikel |
21 |
Segmental volume reduction using thermal vapour ablation in patients with severe emphysema: 6-month results of the multicentre, parallel-group, open-label, randomised controlled STEP-UP trial
|
Herth, Felix J F |
|
2016 |
4 |
3 |
p. 185-193 9 p. |
artikel |
22 |
Sepsis: older and newer concepts
|
Vincent, Jean-Louis |
|
2016 |
4 |
3 |
p. 237-240 4 p. |
artikel |
23 |
Smoke without fire
|
Wilton, Jayne |
|
2016 |
4 |
3 |
p. 184- 1 p. |
artikel |
24 |
Statins and brain dysfunction in intensive care
|
Sharshar, Tarek |
|
2016 |
4 |
3 |
p. 169-170 2 p. |
artikel |
25 |
Steroids reduce respiratory problems in late preterm infants
|
Nelson, Roxanne |
|
2016 |
4 |
3 |
p. 180- 1 p. |
artikel |
26 |
Turkmenistan bans tobacco sales
|
Bagcchi, Sanjeet |
|
2016 |
4 |
3 |
p. 180- 1 p. |
artikel |